News | December 11, 2008

Siemens’ IQ•SPECT Technology Nets FDA Clearance

December 12, 2008 – IQ•SPECT is the newest Symbia feature from Siemens Healthcare that reportedly enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.

Achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions, IQ•SPECT technology combines this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction to enable more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.

IQ•SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.

For more information: www.siemens.com/healthcare


Related Content

News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Home June 11, 2024
Home
News | SPECT-CT

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Home September 12, 2022
Home
News | SPECT-CT

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

Home September 07, 2022
Home
Technology | SPECT-CT

October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens ...

Home October 18, 2016
Home
News | SPECT-CT

May 5, 2016 — Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to ...

Home May 05, 2016
Home
Subscribe Now